Clinical Correlates of Discrepant Results of Chromogranin a versus Serotonin Markers in Patients with Neuroendocrine Tumors
#1917
Introduction: Neuroendocrine tumors lead to elevated chromogranin A levels and elevated serotonin markers (urinary 5HIAA and platelet serotonin). These markers are employed for diagnosis and monitoring.
Aim(s): To determine the clinical correlates of chromogranin A levels discrepant to serotonin markers.
Materials and methods: Chromogranin A, urine 5HIAA and platelet serotonin were evaluated in 143 patients with neuroendocrine tumors (grade 1 and 2) and neuroendocrine cancers (grade 3) from 2005 to 2015.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Meijer W
Authors: Meijer W, Bruikman C, Beukeveld G,
Keywords: neuroendocrine tumors, chromogranin A, urinary 5HIAA, platelet serotonin,
To read the full abstract, please log into your ENETS Member account.